Similar articles

• Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.

  Mäkinen T, Tammela TL, Hakama M, Stenman UH, Rannikko S, Aro J, Juusela H, Määttänen L, Auvinen A. Mäkinen T, et al. J Urol. 2001 Oct;166(4):1339-42. J Urol. 2001. PMID: 11547069
• [Elevated PSA--what to do?].

  Machemer H, Rohde D. Machemer H, et al. MMW Fortschr Med. 2008 Oct 30;150(44):38-9. MMW Fortschr Med. 2008. PMID: 19024490 German. No abstract available.
• Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.

  Agalliu I, Weiss NS, Lin DW, Stanford JL. Agalliu I, et al. Cancer Causes Control. 2007 Nov;18(9):931-7. doi: 10.1007/s10552-007-9031-7. Epub 2007 Jul 20. Cancer Causes Control. 2007. PMID: 17641982
• [Value of determining prostate-specific antigen for early detection or prostatic carcinoma].

  Hammerer P, Huland H. Hammerer P, et al. Urologe A. 1995 Jul;34(4):283-9. Urologe A. 1995. PMID: 7545842 Review. German.
• Significance of serum free prostate specific antigen in the screening of prostate cancer.

  Higashihara E, Nutahara K, Kojima M, Okegawa T, Miura I, Miyata A, Kato M, Sugisaki H, Tomaru T. Higashihara E, et al. J Urol. 1996 Dec;156(6):1964-8. J Urol. 1996. PMID: 8911366 Review.